NCT01723319Unknown不适用
A Double Blind Randomized Controlled Evaluation of the HBLPADD-coil Transcranial Magnetic Stimulation (TMS) Device - Efficacy and Safety In Subjects With ADHD.
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Efficacy will be examined by the change in the CAARS questionnaire from the baseline visit to the determination visit in the treatment group compared to the control group.
研究概览
简要总结
Objectives:The purpose of the study is to explore the efficacy and safety of HBLPADD Coil deep brain TMS in subjects with ADHD.
Patient Population: The intention is to treat 40 patients diagnosed with ADHD. The patients will be of all racial, ethnic and gender categories, ranging from 18 to 65 years of age.
Structure: The study is a randomized, prospective, 5 weeks, double blind study. Blinding: The treatment administrator and the study personnel and patients will be masked to the treatment being administrated.
The study group will receive active dTMS treatment and the control group will receive an inactive, sham treatment
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients between the ages of 18-65(male and female).
- •Diagnosed as suffering from Attention-Deficit Hyperactivity Disorder according to the DSM IV.
- •Patients taking medication for ADHD will give their consent to stop those medication 48 before entering the study and throughout the daily treatments.
- •Gave informed consent for participation in the study.
- •If referred by the treating psychiatrist, he or she approves of the subjects participation in the study.
排除标准
- •Suffering from other diagnosis on axis
- •antipsychotic treatment with stabilizers; medications from the Benzodiazepines group are allowed, if need be,to a maximum dosage of 2 mg lorazepam.
- •History of lack of tolerance to TMS.
- •Axis 2 diagnosis according to the DSM IV.
- •Substantial suicidal risk as judged by the treating psychiatrist or by an independent psychiatrist.
- •Attempted suicide in the past year.
- •High and not controlled blood pressure.
- •History of epilepsy, seizure, or hot spasm.
- •History of epilepsy or seizure in first degree relatives.
- •History of a significant head injury
- •History of metal in the head (outside the mouth space).
- •Known history of any metallic particles in the eye, implanted cardiac pacemaker or any intracardiac lines, implanted neurostimulators, surgical clips or any medical pumps.
- •Use of hearing aids for hearing loss.
- •History of frequent or severe headaches.
- •History of drug or alcohol abuse during the last year.
- •Inability to achieve satisfying level of communication with the subject.
- •Participation in current clinical study or clinical study within 30 days prior to this study
- •Patients declared as legally incompetent, with an appointed physical guardian and/or cannot sign informed consent due to cognitive incompetence.
- •Women - Pregnancy or not using a reliable method of birth control.
结局指标
主要结局
Efficacy will be examined by the change in the CAARS questionnaire from the baseline visit to the determination visit in the treatment group compared to the control group.
时间窗: 5 weeks
次要结局
- clinical improvement as measured using Clinical global Impression (CGI).(5 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Tolerability, Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of SchizophreniaSchizophreniaNCT00685321Shalvata Mental Health Center45
Unknown
不适用
Double Blind Randomized Controlled, H1 Coil In Subjects With Bipolar DepressionBipolar DepressionNCT00657735Shalvata Mental Health Center50
Unknown
4 期
Efficacy and Safety of DBS of the GPi in Patients With Primary Generalized and Segmental DystoniaDystoniaNCT00142259German Parkinson Study Group (GPS)40
已完成
不适用
Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD)Huntington DiseaseNCT02535884Heinrich-Heine University, Duesseldorf48
Unknown
不适用
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar DepressionBipolar DepressionNCT01566591Brainsway120